Structures by: Sebbar N. K.
Total: 56
1-[(1-Butyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-3-methylquinoxalin-2(1<i>H</i>)-one
C16H19N5O
IUCrData (2018) 3, 4 x180482
a=15.8299(8)Å b=10.6270(4)Å c=9.2041(3)Å
α=90° β=98.084(4)° γ=90°
(3<i>S</i>,4<i>S</i>)-4-Phenyl-1,5-bis(prop-2-en-1-yl)-3-(prop-2-en-1-yloxy)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C24H26N2O2
IUCrData (2016) 1, 7 x161175
a=9.6138(2)Å b=8.8891(2)Å c=11.7292(3)Å
α=90° β=97.1270(10)° γ=90°
Ethyl (2<i>E</i>)-3-dimethylamino-2-(5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)prop-2-enoate
C13H17N5O2
IUCrData (2016) 1, 12 x161946
a=7.1482(15)Å b=10.306(2)Å c=19.705(4)Å
α=90° β=99.711(3)° γ=90°
2,3-Dihydrobenz[4,5]imidazo[2,1-<i>b</i>]thiazole
C9H8N2S
IUCrData (2016) 1, 12 x161948
a=12.7440(8)Å b=11.4820(7)Å c=12.8707(8)Å
α=90° β=118.2340(10)° γ=90°
<i>N</i>-{2-[2-(5-Methyl-1<i>H</i>-pyrazol-3-yl)acetamido]phenyl}benzamide monohydrate
C19H18N4O2,H2O
IUCrData (2017) 2, 2 x170251
a=8.4220(3)Å b=10.0410(4)Å c=10.8799(4)Å
α=101.889(2)° β=94.104(2)° γ=90.4020(10)°
<i>trans</i>-Bis(<i>N</i>-{2-[2-(3-methyl-1<i>H</i>-pyrazol-5-yl-κ<i>N</i>^2^)acetamido-κ<i>O</i>]phenyl}benzamide)bis(perchlorato-κ<i>O</i>)copper(II)
C38H36Cl2CuN8O12
IUCrData (2017) 2, 2 x170285
a=8.6572(2)Å b=8.8108(2)Å c=14.2054(3)Å
α=79.4060(10)° β=86.2400(10)° γ=67.8950(10)°
4-Methyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C9H9NOS
IUCrData (2017) 2, 2 x170097
a=7.3148(6)Å b=8.4030(6)Å c=27.670(2)Å
α=90° β=90° γ=90°
1-(3-Phenyl-1<i>H</i>-pyrazol-5-yl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione
C17H12N4O2
IUCrData (2017) 2, 2 x170073
a=12.6320(6)Å b=9.3954(4)Å c=12.3733(6)Å
α=90° β=102.7080(10)° γ=90°
3-Phenylisoxazolin-5-one
C9H7NO2
IUCrData (2017) 2, 1 x170032
a=9.9869(6)Å b=5.3008(3)Å c=13.9874(9)Å
α=90° β=93.106(2)° γ=90°
1-Ethyl-4-phenyl-1,5-benzodiazepine-2-thione
C17H16N2S
IUCrData (2017) 2, 1 x161998
a=8.4001(8)Å b=9.6239(9)Å c=18.0037(18)Å
α=90° β=90° γ=90°
(2<i>Z</i>)-4-Benzyl-[(4-chlorophenyl)methylidene]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C22H16ClNOS
IUCrData (2016) 1, 5 x160764
a=11.8931(11)Å b=6.5358(6)Å c=22.817(2)Å
α=90° β=93.2390(10)° γ=90°
2-(2-Amino-5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)acetohydrazide monohydrate
C8H11N7O,H2O
IUCrData (2016) 1, 6 x160870
a=7.2648(3)Å b=8.7228(4)Å c=8.9297(4)Å
α=82.834(2)° β=71.465(2)° γ=85.4780(10)°
2-[(2<i>Z</i>)-2-Benzylidene-3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl]acetic acid
C17H13NO3S
IUCrData (2016) 1, 6 x160863
a=8.6760(3)Å b=8.7882(3)Å c=9.8142(4)Å
α=78.2000(10)° β=73.3110(10)° γ=86.2420(10)°
3-Acetyl-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-4-one
C11H10N2O2
IUCrData (2017) 2, 7 x170991
a=3.7716(6)Å b=10.3959(15)Å c=12.3280(18)Å
α=78.017(2)° β=83.431(2)° γ=81.266(2)°
5,6-Dimethyl-2-[(5-methyl-1,2-oxazol-3-yl)methyl]-1-(prop-2-en-1-yl)-1<i>H</i>-1,3-benzodiazole
C17H19N3O
IUCrData (2017) 2, 7 x170647
a=19.6067(6)Å b=5.5438(2)Å c=14.0069(5)Å
α=90° β=99.911(2)° γ=90°
(<i>Z</i>)-2-Benzylidene-3-<i>n</i>-butoxy-2<i>H</i>-1,4-benzothiazine
C19H19NOS
IUCrData (2017) 2, 6 x170890
a=7.7711(6)Å b=10.9897(11)Å c=11.4090(11)Å
α=112.013(9)° β=109.259(8)° γ=98.120(7)°
(<i>Z</i>)-4-<i>n</i>-Butyl-2-(4-chlorobenzylidene)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C19H18ClNOS
IUCrData (2017) 2, 6 x170870
a=8.8898(8)Å b=8.9885(9)Å c=12.1973(10)Å
α=89.908(8)° β=84.490(7)° γ=63.534(9)°
3-Chloro-1-ethyl-6-nitro-1<i>H</i>-indazole
C9H8ClN3O2
IUCrData (2017) 2, 7 x170972
a=7.4984(3)Å b=16.2805(7)Å c=8.3363(3)Å
α=90° β=97.403(4)° γ=90°
(2<i>Z</i>)-2-Benzylidene-4-octadecyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C33H47NOS
IUCrData (2017) 2, 5 x170695
a=33.8411(7)Å b=4.71060(10)Å c=18.0987(4)Å
α=90° β=90.4700(10)° γ=90°
(2<i>Z</i>)-2-(4-Chlorobenzylidene)-4-[2-(2-oxooxazoliden-3-yl)ethyl]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C20H17ClN2O3S
IUCrData (2017) 2, 5 x170646
a=6.2315(3)Å b=15.5466(8)Å c=18.9162(10)Å
α=90° β=98.8450(10)° γ=90°
(<i>Z</i>)-2-(2-Chlorobenzylidene)-4-(prop-2-ynyl)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C18H12ClNOS
IUCrData (2017) 2, 6 x170889
a=13.3937(8)Å b=8.9106(4)Å c=13.3940(7)Å
α=90° β=99.765(5)° γ=90°
4-[(3-Phenyl-4,5-dihydroisoxazol-5-yl)methyl]-2<i>H</i>-benzo[<i>b</i>][1,4]thiazin-3(4<i>H</i>)-one
C18H16N2O2S
IUCrData (2016) 1, 6 x161012
a=11.7526(3)Å b=10.4082(3)Å c=25.5656(7)Å
α=90° β=90° γ=90°
(2<i>Z</i>)-2-Benzylidene-4-[(1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C25H20N4OS
IUCrData (2016) 1, 11 x161823
a=21.8833(8)Å b=5.7007(2)Å c=16.8054(6)Å
α=90° β=100.2340(10)° γ=90°
6-Bromo-3-(5-bromohexyl)-2-[4-(dimethylamino)phenyl]-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C20H24Br2N4
Acta Crystallographica Section E (2020) 76, 8 1234-1238
a=8.1488(11)Å b=11.2243(15)Å c=12.6378(17)Å
α=64.049(2)° β=74.184(2)° γ=86.067(2)°
4-[(4-Allyl-2-methoxyphenoxy)methyl]-1-(4-methoxyphenyl)-1<i>H</i>-1,2,3-triazole
C20H21N3O3
Acta Crystallographica Section E (2020) 76, 6 962-966
a=16.212(3)Å b=5.9584(12)Å c=19.450(4)Å
α=90° β=110.537(3)° γ=90°
(<i>Z</i>)-4-Hexyl-2-(4-methylbenzylidene)-2<i>H</i>-benzo[<i>b</i>][1,4]thiazin-3(4<i>H</i>)-one
C22H25NOS
Acta Crystallographica Section E (2020) 76, 6 889-895
a=8.8581(19)Å b=9.183(2)Å c=13.021(3)Å
α=106.474(3)° β=109.398(3)° γ=93.383(3)°
Ethyl 2-[(2<i>Z</i>)-2-(2-chlorobenzylidene)-3-oxo-3,4-dihydro-2<i>H</i>-\ 1,4-benzothiazin-4-yl]acetate
C19H16ClNO3S
Acta Crystallographica Section E (2020) 76, 5 629-636
a=11.6882(2)Å b=9.0903(2)Å c=16.9533(3)Å
α=90° β=105.1050(10)° γ=90°
1-(1,3-Benzothiazol-2-yl)-3-(2-hydroxyethyl)imidazolidin-2-one
C12H13N3O2S
Acta Crystallographica Section E (2020) 76, 3 370-376
a=7.2863(2)Å b=13.9178(5)Å c=11.6156(4)Å
α=90° β=98.8660(10)° γ=90°
(2<i>Z</i>)-2-(2,4-Dichlorobenzylidene)-4-nonyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C24H27Cl2NOS
Acta Crystallographica Section E (2020) 76, 2 281-287
a=8.9961(3)Å b=10.3755(3)Å c=13.2565(4)Å
α=73.8570(10)° β=88.1190(10)° γ=74.1820(10)°
1-Benzyl-3-[(1-benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one monohydrate
C24H21N5O,H2O
Acta Crystallographica Section E (2020) 76, 1 95-101
a=9.0872(2)Å b=21.1012(4)Å c=11.7134(2)Å
α=90° β=112.6540(10)° γ=90°
1-Methyl-3-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C11H10N2O
Acta Crystallographica Section E (2019) 75, 12 1940-1946
a=7.1507(3)Å b=8.8177(4)Å c=15.4602(7)Å
α=90° β=97.914(2)° γ=90°
Ethyl 2-{4-[(2-ethoxy-2-oxoethyl)(phenyl)carbamoyl]-2-oxo-1,2-\ dihydroquinolin-1-yl}acetate
C24H24N2O6
Acta Crystallographica Section E (2019) 75, 11 1753-1758
a=16.9368(5)Å b=15.4130(4)Å c=18.4562(6)Å
α=90° β=109.254(4)° γ=90°
(2<i>Z</i>)-4-Benzyl-2-(2,4-dichlorobenzylidene)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C22H15Cl2NOS
Acta Crystallographica Section E (2019) 75, 11 1650-1656
a=9.0373(7)Å b=16.6798(13)Å c=12.5110(10)Å
α=90° β=95.982(2)° γ=90°
Methyl 4-[3,6-bis(pyridin-2-yl)pyridazin-4-yl]benzoate
C22H16N4O2
Acta Crystallographica Section E (2019) 75, 11 1672-1678
a=6.04640(10)Å b=11.7175(3)Å c=13.2931(3)Å
α=95.7350(10)° β=95.8130(10)° γ=101.7800(10)°
1-[(1-Butyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3-methylquinoxalin-2(1<i>H</i>)-one
C16H19N5O
Acta Crystallographica Section E (2018) 74, 12 1815-1820
a=5.3265(2)Å b=9.9946(4)Å c=14.5414(5)Å
α=103.054(2)° β=100.039(2)° γ=93.108(2)°
5-Methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine
C6H6N4
Acta Crystallographica Section E (2018) 74, 12 1833-1837
a=3.7910(2)Å b=18.0092(10)Å c=9.0069(5)Å
α=90° β=101.704(2)° γ=90°
1-Benzyl-3-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C17H14N2O
Acta Crystallographica Section E (2018) 74, 12 1842-1846
a=8.3567(2)Å b=9.2040(2)Å c=17.7868(4)Å
α=90° β=94.5590(10)° γ=90°
1-{[2-Oxo-3-(prop-1-en-2-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-1-yl)methyl}-3-(prop-1-en-2-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C21H20N4O2
Acta Crystallographica Section E (2018) 74, 12 1746-1750
a=11.5244(5)Å b=8.6312(4)Å c=17.9845(8)Å
α=90° β=94.1340(10)° γ=90°
(4<i>Z</i>)-1-Butyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C16H20N2O2
Acta Crystallographica Section E (2018) 74, 11 1669-1673
a=9.1132(6)Å b=12.6676(9)Å c=12.8164(9)Å
α=91.3440(10)° β=99.5370(10)° γ=96.3400(10)°
Ethyl 2-{4-[(3-methyl-2-oxo-1,2-dihydroquinoxalin-1-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C16H17N5O3
Acta Crystallographica Section E (2018) 74, 11 1648-1652
a=7.2061(15)Å b=10.237(2)Å c=10.694(2)Å
α=95.356(3)° β=92.867(3)° γ=100.291(3)°
(2<i>Z</i>)-2-(2,4-Dichlorobenzylidene)-4-[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C20H16Cl2N2O3S
Acta Crystallographica Section E (2019) 75, 5 593-599
a=18.4615(8)Å b=12.8567(5)Å c=7.9251(4)Å
α=90° β=96.926(2)° γ=90°
(2<i>Z</i>)-2-(4-Fluorobenzylidene)-4-(prop-2-yn-1-yl)-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C18H12FNOS
Acta Crystallographica Section E (2019) 75, 3 372-377
a=4.0602(2)Å b=13.8983(5)Å c=14.2620(5)Å
α=117.809(2)° β=93.155(2)° γ=94.416(2)°
3-(4,4-Dimethyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-ylidene)-6-methyl-3,4-dihydro-2<i>H</i>-pyran-2,4-dione
C17H18N2O3
Acta Crystallographica Section E (2019) 75, 2 228-232
a=5.53730(10)Å b=24.0197(4)Å c=11.7815(3)Å
α=90° β=103.488(2)° γ=90°
3-{(2<i>Z</i>)-2-[(2,4-Dichlorophenyl)methylidene]-3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl}propanenitrile
C18H12Cl2N2OS
Acta Crystallographica Section E (2019) 75, 6 721-727
a=6.5687(6)Å b=7.9971(7)Å c=15.4939(13)Å
α=98.105(4)° β=94.316(4)° γ=95.002(4)°
2-Chloroethyl 2-oxo-1-(prop-2-yn-1-yl)-1,2-dihydroquinoline-4-carboxylate
C15H12ClNO3
Acta Crystallographica Section E (2019) 75, 10 1411-1417
a=7.1809(2)Å b=21.4466(5)Å c=8.9173(2)Å
α=90° β=92.784(2)° γ=90°
4-[(Prop-2-en-1-yloxy)methyl]-3,6-bis(pyridin-2-yl)pyridazine
C18H16N4O
Acta Crystallographica Section E (2019) 75, 9 1321-1326
a=8.9420(2)Å b=15.1130(3)Å c=11.5829(3)Å
α=90° β=100.1320(10)° γ=90°
(<i>Z</i>)-Ethyl 2-{5-[(2-benzylidene-3-oxo-2,3-dihydrobenzo[<i>b</i>][1,4]thiazin-4-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C22H20N4O3S
Acta Crystallographica Section E (2015) 71, 12 o1022-o1023
a=9.9767(6)Å b=8.7342(5)Å c=23.1027(14)Å
α=90° β=94.5080(10)° γ=90°
(<i>Z</i>)-2-Benzylidene-4-methyl-2<i>H</i>-benzo[<i>b</i>][1,4]thiazin-3(4<i>H</i>)-one
C16H13NOS
Acta Crystallographica Section E (2015) 71, 11 o862-o863
a=9.1497(3)Å b=14.7052(5)Å c=10.0037(3)Å
α=90° β=97.0510(10)° γ=90°
4-Benzyl-2<i>H</i>-benzo[<i>b</i>][1,4]thiazin-3(4<i>H</i>)-one
C15H13NOS
Acta Crystallographica Section E (2015) 71, 12 o999
a=10.8711(7)Å b=5.3815(3)Å c=21.1997(13)Å
α=90° β=93.1280(10)° γ=90°
(<i>E</i>)-2-Benzylidene-4-[(3-phenyl-4,5-dihydroisoxazol-5-yl)methyl]-2<i>H</i>-benzo[<i>b</i>][1,4]thiazin-3(4<i>H</i>)-one
C25H20N2O2S
Acta Crystallographica Section E (2015) 71, 6 o423-o424
a=17.4463(16)Å b=5.3024(4)Å c=22.778(2)Å
α=90° β=106.370(5)° γ=90°
4-(Prop-2-ynyl)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C11H9NOS
Acta Crystallographica Section E (2014) 70, 6 o641
a=9.005(2)Å b=10.889(3)Å c=10.341(3)Å
α=90.00° β=104.565(7)° γ=90.00°
(2<i>Z</i>)-2-Benzylidene-4-<i>n</i>-utyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C19H19NOS
Acta Crystallographica Section E (2014) 70, 6 o686
a=8.7717(13)Å b=8.8631(13)Å c=12.3184(16)Å
α=88.283(9)° β=82.302(9)° γ=60.895(8)°
Ethyl 2-{5-[(3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C15H16N4O3S
Acta Crystallographica Section E (2014) 70, 2 o116
a=5.6414(2)Å b=11.1604(4)Å c=13.3724(5)Å
α=73.823(2)° β=87.226(2)° γ=88.566(2)°
4-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C18H16N4OS
Acta Crystallographica Section E (2014) 70, 2 o160-o161
a=13.283(2)Å b=5.3661(10)Å c=23.281(4)Å
α=90.00° β=96.633(10)° γ=90.00°
4-[(1-Benzyl-1,2,3-triazol-5-yl)methyl]-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C18H16N4OS
Acta Crystallographica Section E (2014) 70, 3 o363-o364
a=34.5438(15)Å b=6.0102(2)Å c=15.6138(7)Å
α=90.00° β=90.00° γ=90.00°
(2<i>Z</i>)-2-Benzylidene-4-(prop-2-yn-1-yl)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C18H13NOS
Acta Crystallographica Section E (2014) 70, 5 o614
a=9.0254(13)Å b=7.7388(12)Å c=42.488(7)Å
α=90.00° β=90.00° γ=90.00°